Fig. 2
From: Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case
Predicted HIV-1 peptides homologous to tumor antigens. Cumulative number of HIV-1 predicted antigens homologous to TAAs from all cancer-specific proteins identified in each tumor (A). Number of HIV-1 predicted antigens associated to each HLA allele homologous to TAAs from all cancer-specific proteins identified in each tumor, listed by cancer (B). Number of HIV-1 predicted antigens associated to each HLA allele homologous to TAAs from each cancer-specific proteins identified in each tumor, listed by protein (C). Cumulative predicted affinity of HIV-1 predicted antigens listed by HLA allele (D)